You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 166 No. 20, November 13, 2006 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Investigation
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (55)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Drug Therapy
 •Adverse Effects
 •Immunology
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Guillain-Barré Syndrome After Influenza Vaccination in Adults

A Population-Based Study

David N. Juurlink, MD, PhD; Therese A. Stukel, PhD; Jeffrey Kwong, MD, MSc; Alexander Kopp, BA; Allison McGeer, MD, MSc; Ross E. Upshur, MD, MSc; Douglas G. Manuel, MD, MSc; Rahim Moineddin, PhD; Kumanan Wilson, MD, MSc

Arch Intern Med. 2006;166:2217-2221.

Background  Whether influenza vaccination is associated with Guillain-Barré syndrome (GBS) remains uncertain.

Methods  We conducted 2 studies using population-based health care data from the province of Ontario, Canada. In the first study, we used the self-matched case-series method to explore the temporal association between probable influenza vaccination (adults vaccinated during October and November) and subsequent hospitalization because of GBS. In the second study, we used time-series analysis to determine whether the institution of a universal influenza immunization program in October 2000 was associated with a subsequent increase in hospital admissions because of GBS at the population level.

Results  From April 1, 1992, to March 31, 2004, we identified 1601 incident hospital admissions because of GBS in Ontario. In 269 patients, GBS was diagnosed within 43 weeks of vaccination against influenza. The estimated relative incidence of GBS during the primary risk interval (weeks 2 through 7) compared with the control interval (weeks 20 through 43) was 1.45 (95% confidence interval, 1.05-1.99; P = .02). This association persisted in several sensitivity analyses using risk and control intervals of different durations. However, a separate time-series analysis demonstrated no evidence of seasonality and revealed no statistically significant increase in hospital admissions because of GBS after the introduction of the universal influenza immunization program.

Conclusion  Influenza vaccination is associated with a small but significantly increased risk for hospitalization because of GBS.


Author Affiliations: Institute of Clinical Evaluative Sciences (Drs Juurlink, Stukel, Kwong, and Manuel and Mr Kopp), Primary Care Research Unit (Dr Upshur), Sunnybrook and Women's College Health Sciences Centre, and Departments of Medicine (Drs Juurlink, McGeer, Moineddin, and Wilson), Health Policy Management and Evaluation (Drs Juurlink, McGeer, and Wilson), Public Health Sciences (Dr Upshur), and Microbiology, Mount Sinai Hospital (Dr McGeer), University of Toronto; and Toronto General Research Institute, Toronto General Hospital (Dr Wilson), Toronto, Ontario.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Guillain-Barre Syndrome, Influenzalike Illnesses, and Influenza Vaccination During Seasons With and Without Circulating A/H1N1 Viruses
Grimaldi-Bensouda et al.
Am J Epidemiol 2011;174:326-335.
ABSTRACT | FULL TEXT  

Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe
Dieleman et al.
BMJ 2011;343:d3908-d3908.
ABSTRACT | FULL TEXT  

A 29-Year-Old Woman With Flu-like Symptoms: Review of Influenza Diagnosis and Treatment
Barry
JAMA 2010;304:671-678.
ABSTRACT | FULL TEXT  

Utility of Influenza Vaccination for Oncology Patients
Pollyea et al.
JCO 2010;28:2481-2490.
ABSTRACT | FULL TEXT  

Near Real-Time Surveillance for Influenza Vaccine Safety: Proof-of-Concept in the Vaccine Safety Datalink Project
Greene et al.
Am J Epidemiol 2010;171:177-188.
ABSTRACT | FULL TEXT  

Should I have an H1N1 flu vaccination after Guillain-Barre syndrome?
Price
BMJ 2009;339:b3577-b3577.
FULL TEXT  

"Prepandemic" Immunization for Novel Influenza Viruses, "Swine Flu" Vaccine, Guillain-Barre Syndrome, and the Detection of Rare Severe Adverse Events
Evans et al.
The Journal of Infectious Disease 2009;200:321-328.
ABSTRACT | FULL TEXT  

Investigation of the Temporal Association of Guillain-Barre Syndrome With Influenza Vaccine and Influenzalike Illness Using the United Kingdom General Practice Research Database
Stowe et al.
Am J Epidemiol 2009;169:382-388.
ABSTRACT | FULL TEXT  

Guillain-Barre Syndrome and Influenza Virus Infection
Sivadon-Tardy et al.
Clinical Infectious Diseases 2009;48:48-56.
ABSTRACT | FULL TEXT  

Anti-Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine-Associated Guillain-Barre Syndrome
Nachamkin et al.
The Journal of Infectious Disease 2008;198:226-233.
ABSTRACT | FULL TEXT  

Incidence of Guillain-Barre syndrome in Alberta, Canada: an administrative data study
Hauck et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:318-320.
ABSTRACT | FULL TEXT  

Optic Neuritis and Vaccination Investigation: Failure to Consider Significant Sex Differences and Multiple Vaccine Combinations
Engler et al.
Arch Neurol 2007;64:1673-1674.
FULL TEXT  

Flu Vaccine and GBS: Two Studies, No Answer
JWatch Infect. Diseases 2006;2006:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.